Geode Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.7M | Sell |
|
|||||
|
2025
Q2 | $92.9M | Buy |
|
|||||
|
2025
Q1 | $77.6M | Buy |
|
|||||
|
2024
Q4 | $92.2M | Sell |
|
|||||
|
2024
Q3 | $96M | Buy |
|
|||||
|
2024
Q2 | $97M | Buy |
|
|||||
|
2024
Q1 | $96.1M | Buy |
|
|||||
|
2023
Q4 | $92.8M | Buy |
|
|||||
|
2023
Q3 | $92.6M | Buy |
|
|||||
|
2023
Q2 | $84.4M | Buy |
|
|||||
|
2023
Q1 | $78.1M | Buy |
|
|||||
|
2022
Q4 | $71.6M | Buy |
|
|||||
|
2022
Q3 | $65.6M | Buy |
|
|||||
|
2022
Q2 | $56.4M | Sell |
|
|||||
|
2022
Q1 | $55.7M | Buy |
|
|||||
|
2021
Q4 | $45M | Buy |
|
|||||
|
2021
Q3 | $58.7M | Sell |
|
|||||
|
2021
Q2 | $57.1M | Buy |
|
|||||
|
2021
Q1 | $68.5M | Buy |
|
|||||
|
2020
Q4 | $68.6M | Buy |
|
|||||
|
2020
Q3 | $47.5M | Sell |
|
|||||
|
2020
Q2 | $54.5M | Sell |
|
|||||
|
2020
Q1 | $76M | Buy |
|
|||||
|
2019
Q4 | $86M | Buy |
|
|||||
|
2019
Q3 | $91.9M | Buy |
|
|||||
|
2019
Q2 | $84.5M | Buy |
|
|||||
|
2019
Q1 | $57.9M | Buy |
|
|||||
|
2018
Q4 | $62.9M | Buy |
|
|||||
|
2018
Q3 | $68.9M | Sell |
|
|||||
|
2018
Q2 | $55.1M | Buy |
|
|||||
|
2018
Q1 | $37M | Buy |
|
|||||
|
2017
Q4 | $27.7M | Sell |
|
|||||
|
2017
Q3 | $21.5M | Buy |
|
|||||
|
2017
Q2 | $18M | Buy |
|
|||||
|
2017
Q1 | $18.1M | Buy |
|
|||||
|
2016
Q4 | $16.1M | Buy |
|
|||||
|
2016
Q3 | $12.8M | Buy |
|
|||||
|
2016
Q2 | $9.81M | Sell |
|
|||||
|
2016
Q1 | $11.9K | Buy |
|
|||||
|
2015
Q4 | $10.2M | Buy |
|
|||||
|
2015
Q3 | $10.1M | Buy |
|
|||||
|
2015
Q2 | $12.8M | Buy |
|
|||||
|
2015
Q1 | $13.3M | Buy |
|
|||||
|
2014
Q4 | $10.6M | Buy |
|
|||||
|
2014
Q3 | $9.8M | Buy |
|
|||||
|
2014
Q2 | $9.86M | Buy |
|
|||||
|
2014
Q1 | $9.03M | Buy |
|
|||||
|
2013
Q4 | $10.7M | Buy |
|
|||||
|
2013
Q3 | $9.11M | Buy |
|
|||||
|
2013
Q2 | $8.69M | Buy |
|